Substituted triazolopyridines

US9670202B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Hartmut Schirok · Wuppertal, DE
• Volker Schulze · Hohen Neuendorf, DE
• Dirk Kosemund · Berlin, DE
• Hans Briem · Bremen, DE
• Benjamin Bader · Berlin, DE
• Ulf Bömer · Glienicke, DE
• Antje Margret Wengner · Berlin, DE
• Gerhard Siemeister · Berlin, DE
• Philip Lienau · Berlin, DE

Key dates

• Filing date: Jun 3, 2014
• Grant date: Jun 6, 2017
• Expiry date: Jun 3, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to substituted triazolopyridine compounds of general formula (I); in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, as well as to intermediate compounds useful in the preparation of said compounds.